Almost all patients with ALS, and 50% of all FTD cases, are characterised neuropathologically by nuclear clearing and cytoplasmic mislocalisation of the 43-kDa transactive response DNA-binding protein (TDP-43)14,15. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.